148 related articles for article (PubMed ID: 20580431)
21. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
Pradhan P; Giri J; Rieken F; Koch C; Mykhaylyk O; Döblinger M; Banerjee R; Bahadur D; Plank C
J Control Release; 2010 Feb; 142(1):108-21. PubMed ID: 19819275
[TBL] [Abstract][Full Text] [Related]
22. Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): drug release behavior and stability in the presence of serum.
Han HD; Shin BC; Choi HS
Eur J Pharm Biopharm; 2006 Jan; 62(1):110-6. PubMed ID: 16183268
[TBL] [Abstract][Full Text] [Related]
23. Magnetoresponsive on-demand release of hybrid liposomes formed from Fe3 O4 nanoparticles and thermosensitive block copolymers.
Katagiri K; Imai Y; Koumoto K; Kaiden T; Kono K; Aoshima S
Small; 2011 Jun; 7(12):1683-9. PubMed ID: 21567941
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia.
Al-Jamal WT; Al-Ahmady ZS; Kostarelos K
Biomaterials; 2012 Jun; 33(18):4608-17. PubMed ID: 22459195
[TBL] [Abstract][Full Text] [Related]
25. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome.
Tagami T; Foltz WD; Ernsting MJ; Lee CM; Tannock IF; May JP; Li SD
Biomaterials; 2011 Sep; 32(27):6570-8. PubMed ID: 21641639
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound-mediated drug delivery using liposomes modified with a thermosensitive polymer.
Ninomiya K; Kawabata S; Tashita H; Shimizu N
Ultrason Sonochem; 2014 Jan; 21(1):310-6. PubMed ID: 23948493
[TBL] [Abstract][Full Text] [Related]
27. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system.
Tagami T; Ernsting MJ; Li SD
J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149
[TBL] [Abstract][Full Text] [Related]
28. Effect of poly(ethylene glycol) grafts on temperature-sensitivity of thermosensitive polymer-modified liposomes.
Kono K; Yoshino K; Takagishi T
J Control Release; 2002 Apr; 80(1-3):321-32. PubMed ID: 11943408
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics.
Chun C; Lee SM; Kim CW; Hong KY; Kim SY; Yang HK; Song SC
Biomaterials; 2009 Sep; 30(27):4752-62. PubMed ID: 19520429
[TBL] [Abstract][Full Text] [Related]
30. Graft and diblock copolymer multifunctional micelles for cancer chemotherapy and imaging.
Tsai HC; Chang WH; Lo CL; Tsai CH; Chang CH; Ou TW; Yen TC; Hsiue GH
Biomaterials; 2010 Mar; 31(8):2293-301. PubMed ID: 20042234
[TBL] [Abstract][Full Text] [Related]
31. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
32. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
33. A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
Metselaar JM; Bruin P; de Boer LW; de Vringer T; Snel C; Oussoren C; Wauben MH; Crommelin DJ; Storm G; Hennink WE
Bioconjug Chem; 2003; 14(6):1156-64. PubMed ID: 14624629
[TBL] [Abstract][Full Text] [Related]
34. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
Eliaz RE; Szoka FC
Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
[TBL] [Abstract][Full Text] [Related]
35. Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes.
Pan H; Han L; Chen W; Yao M; Lu W
J Control Release; 2008 Feb; 125(3):228-35. PubMed ID: 18022270
[TBL] [Abstract][Full Text] [Related]
36. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
37. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
Chiu GN; Abraham SA; Ickenstein LM; Ng R; Karlsson G; Edwards K; Wasan EK; Bally MB
J Control Release; 2005 May; 104(2):271-88. PubMed ID: 15907579
[TBL] [Abstract][Full Text] [Related]
38. Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
Woo J; Chiu GN; Karlsson G; Wasan E; Ickenstein L; Edwards K; Bally MB
Int J Pharm; 2008 Feb; 349(1-2):38-46. PubMed ID: 17728083
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice.
Al-Abd AM; Hong KY; Song SC; Kuh HJ
J Control Release; 2010 Feb; 142(1):101-7. PubMed ID: 19819274
[TBL] [Abstract][Full Text] [Related]
40. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
Ogawara K; Un K; Tanaka K; Higaki K; Kimura T
J Control Release; 2009 Jan; 133(1):4-10. PubMed ID: 18840484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]